Literature DB >> 16960402

Extrapancreatic proinsulin/insulin-expressing cells in diabetes mellitus: is history repeating itself?

Hideto Kojima1, Mineko Fujimiya, Tomoya Terashima, Hiroshi Kimura, Lawrence Chan.   

Abstract

Insulin is a key regulator of life. Until 25 years ago, the pancreatic beta-cell was thought to be the only organ that produces insulin in the body. Insulin deficiency, whether absolute (in type 1) or relative (in type 2 diabetes), underlies the metabolic derangements in diabetes mellitus, and investigations on insulin have concentrated on pancreatic insulin production, its regulation and the metabolic consequences of insulin deficiency. The thymus was the next organ that was found to also produce insulin, a process that may tolerize the body to the molecule, protecting the host from developing autoimmune beta-cell destruction and (type 1) diabetes. However, now and then there were descriptions of promiscuous insulin production outside the pancreas. During our investigations on diabetes gene therapy in rodents, we serendipitously came across the presence of mysterious cells marked by proinsulin production in unexpected organs, some of which cells may underlie certain chronic diabetic complications. Starting with a historical perspective on insulin expression in brain and thymus, this review focuses mainly on unraveling the mystery of extrapancreatic extrathymic proinsulin/insulin expression in diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16960402     DOI: 10.1507/endocrj.kr-84

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  8 in total

1.  Inactivation of TNF-α ameliorates diabetic neuropathy in mice.

Authors:  Isamu Yamakawa; Hideto Kojima; Tomoya Terashima; Miwako Katagi; Jiro Oi; Hiroshi Urabe; Mitsuru Sanada; Hiromichi Kawai; Lawrence Chan; Hitoshi Yasuda; Hiroshi Maegawa; Hiroshi Kimura
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-02       Impact factor: 4.310

2.  Homing of the bone marrow-derived interstitial cells of Cajal is decreased in diabetic mouse intestine.

Authors:  Yimin Li; Hideto Kojima; Kazunori Fujino; Kazuhiro Matsumura; Miwako Katagi; Hiroshi Urabe; Lawrence Chan; Yutaka Eguchi; Linghui Zhao; Hiroshi Kimura
Journal:  J Gastroenterol Hepatol       Date:  2011-06       Impact factor: 4.029

Review 3.  Alterations of tendons in diabetes mellitus: what are the current findings?

Authors:  Liu Shi; Yun-Feng Rui; Gang Li; Chen Wang
Journal:  Int Orthop       Date:  2015-05-06       Impact factor: 3.075

4.  Immunohistochemical evaluation of hepatic oval cell activation and differentiation toward pancreatic beta-cell phenotype in streptozotocin-induced diabetic mice.

Authors:  M Vorobeychik; K Bloch; R Zemel; L Bachmetov; R Tur-Kaspa; P Vardi
Journal:  J Mol Histol       Date:  2008-07-31       Impact factor: 2.611

5.  Fusion of proinsulin-producing bone marrow-derived cells with hepatocytes in diabetes.

Authors:  Mineko Fujimiya; Hideto Kojima; Masumi Ichinose; Ryohachi Arai; Hiroshi Kimura; Atsunori Kashiwagi; Lawrence Chan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-27       Impact factor: 11.205

Review 6.  Insulin-secreting β cells require a post-genomic concept.

Authors:  Fang-Xu Jiang; Grant Morahan
Journal:  World J Diabetes       Date:  2016-05-25

7.  hZnT8 (Slc30a8) Transgenic Mice That Overexpress the R325W Polymorph Have Reduced Islet Zn2+ and Proinsulin Levels, Increased Glucose Tolerance After a High-Fat Diet, and Altered Levels of Pancreatic Zinc Binding Proteins.

Authors:  Li Li; Shi Bai; Christian T Sheline
Journal:  Diabetes       Date:  2016-11-29       Impact factor: 9.461

Review 8.  The Prohormone Proinsulin as a Neuroprotective Factor: Past History and Future Prospects.

Authors:  Flora de Pablo; Catalina Hernández-Sánchez; Enrique J de la Rosa
Journal:  Front Mol Neurosci       Date:  2018-11-26       Impact factor: 5.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.